Top Markets
Coin of the day
Co.don AG Co.don AG

Co.don AG

CNW
Rang in aandelen #33382
Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as... Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as a global biopharmaceutical firm dedicated to the research, development, and marketing of cell-based pharmaceutical solutions. The company's core focus is on joint preservation and the regenerative repair of articular cartilage defects. Its offerings include Spherox, an advanced three-dimensional chondrocyte product specifically designed to address cartilage damage in adult knee joints. Additionally, co.don AG provides co.don chondrosphere, a therapy utilized for treating cartilage imperfections in younger patients across multiple joints, such as the hip, ankle, shoulder, elbow, and knees. These specialized treatments are primarily employed by orthopedic and trauma surgeons.
Aandeelprijs
$0.29060802
Laatst gesynchroniseerd: 2022-09-30
Marktkapitalisatie
$7.77M
Verandering (1 dag)
-14.30%
Verandering (1 jaar)
0.00%
Land
DE
Handel Co.don AG (CNW)

Categorie

Dividendrendementgeschiedenis voor Co.don AG (CNW)
Het dividendrendement (TTM) van Co.don AG (aandelsymbool: CNW) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Co.don AG (CNW) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten